Today: 3 July 2026
Intel’s 17% slide shakes semiconductor stocks — what Wall Street watches next week
24 January 2026
1 min read

Intel’s 17% slide shakes semiconductor stocks — what Wall Street watches next week

New York, Jan 24, 2026, 12:25 EST — Market closed.

  • Intel slumped 17% on Friday, setting a cautious tone for chip stocks into the weekend.
  • Nvidia gained while other big chip names such as Broadcom and Qualcomm ended lower.
  • Investors now turn to the Fed decision on Jan. 28 and a midweek run of chip earnings.

Intel slid 17% to $45.07 on Friday, putting U.S. semiconductor stocks back on the defensive going into next week. “You have to actually put up the revenue growth to justify the run-up in stocks,” said Julian McManus, a portfolio manager at Janus Henderson. Reuters

The timing matters. About one-fifth of S&P 500 companies are due to report in the coming week, and investors widely expect the Federal Reserve to hold rates steady when it announces its policy decision on Wednesday. With the S&P 500 trading above 22 times expected earnings, “the earnings bar had better be met,” said Chris Galipeau, senior market strategist at Franklin Templeton. Reuters

Intel said it was caught short by demand for server central processors used alongside AI accelerators, and forecast first-quarter revenue of $11.7 billion to $12.7 billion versus analysts’ $12.51 billion estimate, according to LSEG data. Chief Executive Lip-Bu Tan told analysts he was “disappointed” Intel could not fully meet demand, while finance chief David Zinsner said cloud customers “were all a little bit caught off guard,” describing a rush to refresh data-center chips that pair with graphics processing units, or GPUs — chips that do much of the heavy lifting in AI training. Reuters

The rest of the large-cap chip group ended mixed on Friday. Nvidia rose 1.53% to $187.67, while Broadcom fell 1.67% to $320.05 and Qualcomm slipped 1.25% to $155.82.

AMD climbed 2.3% on Friday, extending a winning streak, as investors looked for beneficiaries if Intel’s data-center constraints linger.

One risk for chip bulls is that a tightening supply of memory components — the DRAM and NAND chips that sit alongside processors in PCs and servers — could squeeze margins and slow end demand, even if it lifts pricing for suppliers. Intel cited component shortages and higher memory costs, and Investopedia flagged Micron and other storage names as near-term winners if prices keep rising.

Earnings season now takes over for the sector’s next cues. Texas Instruments is set to webcast its fourth-quarter and full-year 2025 earnings call on Tuesday, Jan. 27, with CEO Haviv Ilan and CFO Rafael Lizardi slated to discuss results and take questions.

ASML, the top supplier of extreme ultraviolet lithography tools used to make leading-edge chips, will publish its fourth-quarter results on Wednesday, Jan. 28, and host a press conference and investor call led by CEO Christophe Fouquet and CFO Roger Dassen.

For semiconductor stocks, Monday’s open will show whether Intel’s drop triggers broader de-risking or stays contained to one name with a supply problem. The next hard catalysts are the Fed decision on Wednesday, Jan. 28, and results from Texas Instruments on Jan. 27 and ASML on Jan. 28.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Asahi Kasei (TSE:3407) wraps up ¥17.86bn buyback, highlights pharma tech scale-up
    July 3, 2026, 4:32 PM EDT. Asahi Kasei (TSE:3407) finished a ¥17.86 billion buyback, taking in 0.75% of its shares and signaling a focus on returns for shareholders. Peptistar has now launched Asahi Kasei's FO-MD system at the plant level, putting its pharmaceutical concentration tech into real-world production. This push could drive earnings through healthcare and process solutions, adding to its main battery and hydrogen businesses. Some risks remain for executing FO-MD and AK1940 at scale. The stock has moved up, but some see valuation still lagging-with fair value estimates pointing to a possible double from here. The story here is tighter capital discipline and a bigger bet on new technology.
Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Previous Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets
Next Story

Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets

Go toTop